Actos Cancer RisksJuly 21, 2011 – Regulators with the European Medicines Agency broke their silence today on the safety of the popular diabetes drug Actos. Although they have decided to keep the drug on the market, wa...Read More
Claims Against GlaxoSmithKlineA health insurance carrier is entitled to names and information identifying its insureds who have sued a pharmaceutical manufacturer, a Philadelphia judge has ruled on an issue of first impression. ...Read More
Improperly Marketed DrugBritish drug maker GlaxoSmithKline PLC improperly marketed the diabetes drug Avandia to South Carolina consumers, hiding the medication's harmful side effects, according to a lawsuit filed by the stat...Read More FEED
Actos Lawsuit - Actos Bladder Cancer Alert
Expert Legal Help for those affected by the serious side effects of the Diabetes drug Actos
Actos is the most popular diabetes drug in the world, having been taken by millions of patients for the treatment of type II diabetes. Unfortunately, recent studies have shown that the drug can carry serious and potentially fatal side effects for its users.
Drug regulatory agencies in both France and Germany have banned the use of Actos following research that showed an increased occurrence of bladder cancer among users.
Although the U.S. Food and Drug Administration has yet to take Actos off the market while it waits for additional research, it has issued a warning to users about the potential risk for actos bladder cancer when the drug is taken for more than a year.
The news of Actos potential cancer risks come as a shock for millions of diabetes patients who, just a few years ago, were advised to switch from Avandia to Actos after the former drug was linked to an increased risk of heart attacks.
Experts fear that millions of patients may be at risk of bladder cancer without knowing the cause or that legal help is available. Lawyers are currently helping those affected by Actos file lawsuits for their injuries or diseases.
If you have taken Actos and been diagnosed with bladder cancer, it is important to speak with a lawyer about your legal options as soon as possible. You may be eligible to file an actos lawsuit. Contact us today for a confidential evaluation. The time to file a claim is limited.
Actos Quick Links
Actos Sales DropJapanese drugmaker Takeda Pharmaceuticals announced this month that profit forecasts for the year would be down nearly 32 percent from last year, when they enjoyed success with the most popular diabetes drug in the world.
The company attributed the losses to the recent $13.3 billion purchase of Swiss drugmaker Nycomed in September, as well as the declining value of the U.S. dollar against the ...
Bladder Cancer Warning on ActosJune 15, 2011 - The FDA released a statement on its website today indicating it would require a label change for the popular diabetes drug Actos to show the drug carries risks of bladder cancer.
The move follows years of testing here and in Europe over the drug’s safety and the decision last week by regulators in France and Germany to ban all new prescriptions of Actos.
A long running F ...
The Health Risks of Actos
The U.S. Food and Drug Administration has issued a warning that the diabetes drug Actos may carry an increased risk of bladder cancer in patients taking the drug for more than a year. However, Actos remains on the market in the U.S. pending the results of further tests.
Similar agencies in both France and Germany have banned the prescription and use of Actos altogether.
The safety measures follow recent reports from several independent studies which showed patients taking the drug Actos were more likely to develop bladder cancer than those taking alternative diabetes drugs.
Bladder cancer is a disease affecting almost 70,000 people per year in the United States. The disease typically develops in the inner lining of the bladder.
Although most cases of bladder cancer are detected at early stages allowing successful treatment, even those in remission require regular checkups and almost 15,000 people per year die from the disease.
Studies in both France and the United States have shown a higher occurrence of bladder cancer in patients taking Actos for longer periods of time and who are taking the highest doses of the drug. The French study, the most comprehensive to date, tracked more than 150,000 people taking the drug.
The maker of Actos, Takeda Pharmaceuticals, made approximately $3.4 billion on the sales of Actos last year and has refused to suspend sales of the drug, claiming that it still has positive effects.
However, legal experts have received inquiries from thousands of patients who may have developed bladder cancer from the drug and they expect that several thousand Actos lawsuits may be filed against Takeda before the proper action is taken.
If you have developed bladder cancer after taking Actos, contact us immediately to learn your legal options. Help is available through an Actos bladder cancer lawsuit that can assist with your treatment and recovery. Time to file, however, is limited. Speak with an actos lawyer today.